This information is solely intended to provide a general overview on the product and must be used for informational purposes only
Each week, the fund determines the amount of options premium it needs to generate relative to its income target, and writes the appropriate amount of call options, while still potentially participating in some of the price appreciation of the equity securities.*** Jeff Chang, President of Vest said, In 2017, Vest revolutionized the market with our Target Income partial covered call strategy, which seeks to generate consistent current income and allow participation in the potential growth of stocks
There is a synthetic version which doctors can prescribe, but which can cause liver damage, serious psychiatric effects and heart and respiratory problems if taken without medical oversight
Proven alternatives deliver comparable results with established safety: tirzepatide monotherapy produces 15-22% weight loss with FDA approval and extensive clinical data, while CagriSema (cagrilintide + semaglutide) delivers 15-25% weight loss with Phase 3 trial validation and clearer path to medical acceptance